Seeking to ramp up the nation’s capacity to administer a possible COVID-19 vaccine, the Trump administration has signed a $138 million deal with the makers of an innovative syringe designed to be used ...

BD (NYSE:BDX) announced Thursday that the company has increased its domestic manufacturing of syringes after the FDA warned about quality issues linked to plastic syringes made in China. Since the FDA ...

FRANKLIN LAKES, N.J., Jan. 13, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $110 million investment to expand its ...

(The Center Square) – A major American medical device manufacturer is investing $110 million to expand production in Nebraska as part of an effort to restore pharmaceutical manufacturing and improve ...

March 21 (Reuters) - Becton Dickinson BDX.N said on Thursday that it will increase production of medical syringes in the United States. The company said since the initial U.S. Food and Drug ...

Becton, Dickinson and Company (BD) has announced its intention to increase US production of syringes after FDA recently reported that its ongoing investigation into quality issues with plastic ...

Medtech giant BD has announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, NE, facility. The investments ...

Pune, Oct. 29, 2020 (GLOBE NEWSWIRE) -- The global prefilled syringes market size is expected to reach USD 10.57 billion by 2027, exhibiting a CAGR of 10.5% during the forecast period. The rising ...